Woolson Daniel 4
4 · ICU MEDICAL INC/DE · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Woolson Daniel
VP, GM-Infusion Capital
Transactions
- Exercise/Conversion
Common Stock
2025-03-07+966→ 11,832 total - Exercise/Conversion
Common Stock
2025-03-07−966→ 0 totalExercise: $0.00From: 2023-03-07Exp: 2025-03-07→ Common Stock (966 underlying) - Tax Payment
Common Stock
2025-03-07$141.97/sh−467$66,300→ 11,365 total - Exercise/Conversion
Common Stock
2025-03-08+2,153→ 13,518 total - Tax Payment
Common Stock
2025-03-08$141.97/sh−953$135,297→ 12,565 total - Award
Common Stock
2025-03-07+4,755→ 11,214 total→ Common Stock (4,755 underlying) - Exercise/Conversion
Common Stock
2025-03-08−2,153→ 9,061 total→ Common Stock (2,153 underlying)
Footnotes (4)
- [F1]These securities are Restricted Stock Units.
- [F2]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- [F3]One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
- [F4]These are restricted stock units that fully vest 3 years from the grant date.